Tamar L. Ben-Shaanan

Tamar L. Ben-Shaanan

Auto-generated profile, based on publicly available information

Tamar L. Ben-Shaanan

Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2017 in Nature Neuroscience
Verified
Journal Article
Closed access
BKBen Korin
Ben Korin
TBTamar L Ben-Shaanan
Tamar L Ben-Shaanan
MSMaya Schiller
Maya Schiller
TDTania Dubovik
Tania Dubovik
HAHilla Azulay-Debby
Hilla Azulay-Debby
ARAsya Rolls
Asya Rolls

4 July 2016 in Nature Medicine
Verified
Journal Article
Closed access
TBTamar L Ben-Shaanan
Tamar L Ben-Shaanan
HAHilla Azulay-Debby
Hilla Azulay-Debby
TDTania Dubovik
Tania Dubovik
ESElina Starosvetsky
Elina Starosvetsky
BKBen Korin
Ben Korin
ARAsya Rolls
Asya Rolls

13 July 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
TBTamar L Ben-Shaanan
Tamar L Ben-Shaanan
MSMaya Schiller
Maya Schiller
HAHilla Azulay-Debby
Hilla Azulay-Debby
BKBen Korin
Ben Korin
NBNadia Boshnak
Nadia Boshnak
ARAsya Rolls
Asya Rolls
Regulating immunity is a leading target for cancer therapy. Here, we show that the anti-tumor immune response can be modulated by the brain’s reward system, a key circuitry in emotional processes. Activation of the reward system in tumor-bearing mice (Lewis lung carcinoma (LLC) and B16 melanoma) using chemogenetics (DREADDs), resulted in reduced tumor weight. This effect was mediated via the sympathetic nervous system (SNS), manifested by an attenuated noradrenergic input to a major immunological site, the bone marrow. Myeloid derived suppressor cells (MDSCs), which develop in the bone marrow, became less immunosuppressive following reward system activation. By depleting or adoptively transferring the MDSCs, we demonstrated that these cells are both necessary and sufficient to mediate reward system effects on tumor growth. Given the central role of the reward system in positive emotions, these findings introduce a physiological mechanism whereby the patient’s psychological state can impact anti-tumor immunity and cancer progression.

18 September 2007 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
TBT L Ben-Shaanan
T L Ben-Shaanan
TBT Ben-Hur
T Ben-Hur
JYJ Yanai
J Yanai

1 October 2017 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
TBTamar Ben-Shaanan
Tamar Ben-Shaanan
MSMaya Schiller
Maya Schiller
ARAsya Rolls
Asya Rolls

26 September 2007 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
SKSophia Katz
Sophia Katz
TBTamir Ben‐Hur
Tamir Ben‐Hur
TBTamar L. Ben‐Shaanan
Tamar L. Ben‐Shaanan
JYJoseph Yanai
Joseph Yanai
A major objective in identifying the mechanisms underlying neurobehavioral teratogenicity in an animal model is the possibility of designing therapies that reverse or offset teratogen‐induced neural damage. In our previous studies, we identified deficits in hippocampal muscarinic cholinergic receptor‐induced translocation of protein kinase C (PKC) γ as the likely central factor responsible for the adverse behavioral effects of pre‐natal heroin exposure. Neural progenitors (NP) have the ability to recover behavioral deficits after focal hippocampal damage. Therefore, we explored whether behavioral and synaptic defects could be reversed in adulthood by neural progenitor grafting. Pregnant mice were injected daily with 10 mg/kg of heroin on gestational days 9–18. In adulthood, offspring showed deficits in the Morris maze, a behavior dependent on the integrity of septohippocampal cholinergic synaptic function, along with the loss of the PKCγ and PKCβII responses to cholinergic stimulation. Mice that were exposed pre‐natally to heroin and vehicle control mice were then grafted in adulthood with NP. Importantly, most grafted cells differentiated to astrocytes. NP reversed the behavioral deficits (p = 0.0043) and restored the normal response of hippocampal PKCγ and PKCβII (p = 0.0337 and p = 0.0265 respectively) to cholinergic receptor stimulation. The effects were specific as the PKCα isoform, which is unrelated to the behavioral deficits, showed almost no changes. Neural progenitor grafting thus offers an animal model for reversing neurobehavioral deficits originating in septohippocampal cholinergic defects elicited by pre‐natal exposure to insults.